Tenet Healthcare Corporation (THC) – What Are Investment Firms Thinking About This Stock?

Shares of Tenet Healthcare Corporation (NYSE:THC) have been assigned an average recommendation of “Moderate Buy” from the twenty-three ratings firms that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating and twenty have issued a buy rating on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $293.48.

A number of equities research analysts recently weighed in on THC shares. Raymond James Financial reaffirmed an “outperform” rating and set a $285.00 price objective on shares of Tenet Healthcare in a research report on Friday, August 14th. The Goldman Sachs Group restated a “buy” rating and issued a $305.00 target price on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Deutsche Bank Aktiengesellschaft upped their target price on Tenet Healthcare from $260.00 to $320.00 and gave the company a “buy” rating in a report on Friday, October 30th. Leerink Partners upped their target price on Tenet Healthcare from $309.00 to $342.00 and gave the company an “outperform” rating in a report on Monday. Finally, Piper Sandler set a $308.00 price target on Tenet Healthcare in a research report on Monday, July 27th.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported quarterly EPS of $6.64, topping the $4.68 consensus estimate, and revenue of $6.28 billion versus expectations of $5.49 billion. Revenue increased 6.5% year over year. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Management raised its 2026 EBITDA outlook, adding to investor optimism about the company’s earnings prospects. Tenet Healthcare stock after Q3: 2026 EBITDA outlook raised
• Positive Sentiment: Barclays raised its price target to $297 from $271 and maintained an “overweight” rating. Truist reaffirmed “buy” and raised its target to $305 from $290, while KeyCorp lifted its target to $300 from $270 and retained “overweight” coverage.
• Positive Sentiment: Wells Fargo, Leerink Partners, and Royal Bank of Canada were also cited as expecting further appreciation in THC shares. Read More., Read More., Read More.
• Neutral Sentiment: Zacks noted increased investor attention to Tenet, but its article focused on factors to consider rather than announcing a specific rating or forecast change. Tenet Healthcare Is a Trending Stock

Tenet Healthcare Stock Performance

Shares of THC opened at $291.26 on Friday. The stock has a market capitalization of $23.18 billion, a PE ratio of 8.45, a price-to-earnings-growth ratio of 1.43 and a beta of 1.20. The business’s fifty day moving average price is $264.75 and its 200 day moving average price is $221.49. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.58 and a quick ratio of 1.52. Tenet Healthcare has a 12-month low of $157.58 and a 12-month high of $294.11.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The company had revenue of $6.28 billion for the quarter, compared to analysts’ expectations of $5.49 billion. During the same period in the prior year, the company earned $3.70 earnings per share. The firm’s revenue was up 6.5% compared to the same quarter last year. Equities research analysts forecast that Tenet Healthcare will post 22.32 EPS for the current year.

Insider Activity

In other Tenet Healthcare news, Director J. Robert Kerrey sold 12,010 shares of the stock in a transaction on Monday, September 14th. The stock was sold at an average price of $263.72, for a total value of $3,167,277.20. Following the sale, the director directly owned 4,794 shares of the company’s stock, valued at $1,264,273.68. This trade represents a 71.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Tammy Romo sold 2,500 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $260.83, for a total value of $652,075.00. Following the completion of the sale, the director owned 28,284 shares in the company, valued at $7,377,315.72. The trade was a 8.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 100,962 shares of company stock worth $27,440,309 over the last 90 days. Insiders own 0.97% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several hedge funds have recently bought and sold shares of the company. Lido Advisors LLC bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth about $666,000. M&G PLC bought a new position in shares of Tenet Healthcare in the third quarter valued at approximately $14,609,000. AlphaCore Capital LLC bought a new position in shares of Tenet Healthcare in the third quarter valued at approximately $244,000. Leuthold Group LLC increased its stake in shares of Tenet Healthcare by 8.6% during the third quarter. Leuthold Group LLC now owns 34,405 shares of the company’s stock valued at $8,793,000 after acquiring an additional 2,730 shares during the period. Finally, Retirement Systems of Alabama raised its holdings in Tenet Healthcare by 2.6% during the third quarter. Retirement Systems of Alabama now owns 153,307 shares of the company’s stock worth $39,179,000 after purchasing an additional 3,860 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.